The 17th Annual
Pain Therapeutics Summit
About the Summit
ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT, taking place in San Diego, CA on October 19-20, 2023, is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the biopharmaceutical industry, academia and government attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, academia, clinical research organizations, and government.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products.
Key Subjects Covered at this Event
Clinical Trial Study Design
Trends in Pain Research
Novel Pain Drug Targets
Genetic Components of Pain
Emerging Pain Drug Candidates
Pain Biomarkers
Why You Should Attend
Partnering Software & Meetings
Easily schedule meetings with our partnering system in order to maximize your time at the event. Schedule one-to-one meetings in advance and stay connected after the event.
Discover & Learn
Learn about the latest developments in the field of pain drug development and discover what innovative new therapies are driving investment and clinical development
CRO Service Providers
Meet with and/or re-connect with exhibitors and service providers and learn about the latest tools and resources driving pain drug development and future research trends.
What Past Attendees Have to Say
As a small company in nonclinical development of our non-opiate pain medication, I found the Pain Summit to be uniquely valuable, for several reasons. First, the quality and level of speakers was exceptionally good, and brought our thinking to the highest possible level. Second, the mix of NIH policy, senior clinical researchers, and industry contacts was also very good. Third, the way the Pain Summit was structured, there was time to introduce ourselves to key players. This was one of the best conferences I have ever attended, and I look forward to 2019.
I found the conference not only very informative but also entertaining, with very high quality speakers.
It is a nice snapshot of scientific activity and a look at what may be on the horizon in the pain space.
This is always a delightful and informative session.
Greatest importance of this meeting is challenging participants at every level (discovery through clinical development) on conducting optimally validated research to speed up quality drug development.
From a student perspective, I really thought this conference was valuable and eye-opening. Now I have some ideas on how to conduct better research, and have networked with many professionals at the Summit. Would highly recommend to both students and working professionals.
The Arrowhead Summit is a comprehensive mix of the latest in pre-clinical, mechanistic work in pain drug development along with a nice overview of current clinical trial advancements in this therapeutic area.
Good balance of new potential therapeutics as well as understanding a range of methodological issues that need to be recognized and adequately dealt with in order to conduct quality studies.
Outstanding meeting of many experts focused on new preclinical and clinical approaches to pain management. Lots of valuable insights and new directions to follow.
The conference was a very well balanced session with high quality, innovative attendees, informative sessions and great organization. I'm excited for next year's conference.
I thought your meeting was a great success. Many members of our team commented that it was one of the most informative meetings they have been to in a very long time. Congratulations on its success.
Excellent meeting to present data on innovative analgesic development programs. Also, the meeting provides valuable opportunities for networking with KOLs.
A great meeting to get to know those on the forefront of pain development.
Excellent high level conference on development of novel analgesic therapeutics - and the challenges in achieving success in this field.
This was a truly unique assemblage of throught leaders in pain research and investigators doing cutting edge research
I enjoyed the experience and thought the program was a lovely balance of topics across advances in the development space and in the laboratory. The ease to meet and speak to people was also excellent.
The meeting was excellent and even better than the one I attended 2 years ago in San Diego. I believe that the Washington DC location provides the best opportunity to gather speakers from industry, academia, and Government. I thought the quality of the speakers was very good and I heard very positive comments also from several of the other attendees. For AnaBios it was also a good opportunity to develop some good business leads, so we are happy about the event potential return.
Who Has Attended
Abbott Laboratories | Acura Pharmaceuticals | Adolor Corporation | Adynxx Inc. | Aestus Therapeutics | Afferent Pharmaceuticals | AIT Laboratories | Alder Biopharmaceuticals | Algos Preclinical Services | Alta Life Sciences LLC | Ameritox | Amgen | Anabios Corporation | Analgesic Solutions | Anvyl LLC | Archimedes Pharma | Arcion Therapeutics | Array Biopharma | Astellas Pharma Europe | AstraZeneca | Atlantic Pharmaceuticals Inc | Avigen | Benitec Biopharma | BioAssets Development Corporation | Biogen Idec | BioLineRx | Bionomics | bvBiovail | BioVasc Inc. | Cadence Pharmaceuticals | Camargo Pharma Services | Cambridge Consultants Ltd. | Cara Therapeutics | Cardiome Pharma Corp. | Carnegie Mellon University | Celgene Corp. | Cephalon, Inc. | CG Pharmaceuticals | ChanTest | Chromocell Corporation | Clinical Trial Centers | Clinsys Clinical Research | CNS Drug Consulting | CNSBio Inc. | COLLEGIUM Pharma | Covidien | CRI Lifetree | CRI Worldwide | CrystalGenomics, Inc. | Cubist Pharmaceuticals | DARA BioSciences, Inc | Decision Line Clinical | Defined Health | Dendreon Corporation | Depomed | Domain Associates | Dr. Kade Pharma GmbH | Dr. Reddy's Laboratories | DURECT Corporation | Elanco Animal Health | Eli Lilly & Co | Ethypharm USA | Eurand | Eurofins Prod Safety Labs | FDA | Forest Research Institute | Franklin Pharmacy | Genentech | Genzyme | GIST | GlaxoSmithKline | Glenmark Therapeutics Inc. | Grünenthal GmbH | GVK Biosciences | GW Pharma | Hospira, Inc. | Hydra Biosciences | i3 Research | Icagen | ICON Development | I-Flow, LLC | Indiana University | INFARMED, .I.P. | Integrated Circle of Care Inc. | Ironwood Pharmaceuticals | Isis Pharmaceuticals | J. Bolen Group, LLC | Janssen Pharmaceuticals | Janssen Research | Javelin Pharmaceuticals | Jennersville Hospital | Johnson & Johnson Pharmaceutical | KAI Research Inc. | KCI | King Pharmaceuticals | Labopharm Inc. | Lotus Clinical Research | Lpath | Mass. General Hospital | McGill University | McLean Hospital | MD Biosciences | MedImmune | Medtox Laboratories | Medtronic | Merck & Co., Inc. | Millipore | Mitsubishi Tanabe | MRC Technology | Natixis Bleichroeder | Nektar Therapeutics | NeurAxon | NeuroDiscovery Group | Neuromed | Newron Pharma | NINR, NIH | NMS Labs | North Star Consulting | NovaBay Pharma | Noveida | Nuvo Research | Nycomed | NYU School of Medicine | Omneuron, Inc. | Orexo AB | Origin BioMed Inc. | Ormskirk Hospital | Pacira Pharmaceuticals | Pain Ceptor Pharma | Pain Insights, Inc. | Pain Research Forum | PainReform | Pappas Ventures | PAREXEL International | Pfizer VMRD | PharmacoFore | PharmaNet-i3 | Pharmidex | Phosphagenics | PLX Pharma | Precise Clinical Research | Premier Research | Prescription Drug Research Center | Product Safety Labs | PsychoGenics Inc. | Purdue Pharma | QRx Pharma | Radical Group | Regeneron | Regeneron Pharmaceuticals | ResearchPoint | Ricerca Biosciences | RoxRo Pharma | sanofi Aventis | Schwarz BioSciences | SCOLR Pharma | Scripps Research Institute | Sepracor | Shaare Zedec Medical Center | Shire Pharmaceuticals | Solimar Therapeutics, Inc. | St. Louis University | Stanford Pain Medicine Center | Stanford University | Stanford University School of Medicine | Studylog Systems | Sungsil University | Sunovion Pharmaceticals| Susquehanna Financial | Synergenics, LLC | Synergy Clinical Research | Syntaxin Ltd | Takeda Pharmaceutical Company | Temple Univ. Beasley School of Law | Temple University School of Pharmacy | Teva Pharmaceuticals | The May Day Fund |The Pain Treatment Center of the Bluegrass | The Scripps Research Institute | Theorem Clinical Research | TheraQuest Biosciences | Theravance | Trevena Inc. | Trillium Medical Ventures | Trinity Partners | U. Iowa Carver College of Med., Dept. of Pharmacology & Anesthesia | UC Davis | UCSD | UCSF | UMDNJ | University of Adelaide | University of Arizona | University of California San Francisco | University of California, Irvine | University of Kentucky | University of Pittsburgh | University of Rochester Medical Center | Vertex Pharmaceuticals | Victory Pharma | Vince and Associates Clinical Research | Vivozon, Inc | VM Pharma | Washington University | Washington University in St. Louis | Wright State University School of Medicine | Wyeth | Wyeth Research | Xalud Therapeutics | Xanodyne Pharmaceuticals | Xenome | Xenon Pharmaceuticals Inc. | XenoPort | Zalicus | Zogenix